Spectrum Pharmaceuticals, Inc. (SPPI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:38PM EST. Market open.
| Previous close | 0.6280 |
| Open | 0.6500 |
| Bid | 0.6902 x 800 |
| Ask | 0.6903 x 900 |
| Day's range | 0.6400 - 0.7226 |
| 52-week range | 0.6000 - 4.5400 |
| Volume | |
| Avg. volume | 5,207,922 |
| Market cap | 113.179M |
| Beta (5Y monthly) | 1.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 18 Dec 2012 |
| 1y target est | N/A |
- Zacks
Do Options Traders Know Something About Spectrum Pharmaceuticals (SPPI) Stock We Don't?
Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.
- Zacks
Down 38% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI)
The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Motley Fool
Spectrum Pharmaceuticals, inc (SPPI) Q3 2021 Earnings Call Transcript
Joining me on the call today from Spectrum Pharmaceuticals will be Joe Turgeon, President and CEO; and Dr. Francois Lebel, our Chief Medical Officer. Before we get started, I would like to reference the notice regarding forward-looking statements included in today's press release.
© 2022 Yahoo. All rights reserved.
